Gary Bridger's Net Worth
$66.6 Thousand
Who is Gary Bridger?
Gary Bridger does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ALDER BIOPHARMACEUTICALS INC, Xenon Pharmaceuticals Inc., AQUINOX PHARMACEUTICALS, INC, and X4 Pharmaceuticals, Inc.
SEC CIK
Gary Bridger's CIK is 0001600049
Past Insider Trading and Trends
2019 was Gary Bridger's most active year for acquiring shares with 3 total transactions. Gary Bridger's most active month to acquire stocks was the month of February. 2021 saw Gary Bridger paying a total of $57,000.00 for 6,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALDER BIOPHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.47M |
—
|
—
|
0
|
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
∞
| 3.47M |
$10.00 |
—
| 3.47M |
May 13
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Xenon Pharmaceuticals Inc. (XENE) Snapshot price: $38.47
EVP, Research & Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AQUINOX PHARMACEUTICALS, INC (NLTX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
| -100.00% | -1.54M |
—
|
—
|
0
|
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
| +2.42% | 36.5K |
—
|
—
| 1.54M |
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
X4 Pharmaceuticals, Inc (XFOR) Snapshot price: $0.6887
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +87.10% | 45K |
—
|
—
| 96.67K |
Jun 10
| |||
Form 4
| +674.97% | 45K |
—
|
—
| 51.67K |
Jun 13
| |||
Form 4
|
∞
| 6.67K |
—
|
—
| 6.67K |
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||